Intervention | Group | Cost/QALY | Evidence |
---|---|---|---|
Simvastatin5 | Men with IHD | US$5400 | SSSS trial + projection |
Abciximab1 | High risk patients undergoing PTCA | AU$5547 | EPIC trial + model |
Simvastatin5 | Women with IHD | US$10500 | SSSS trial + projection |
t-PA (cf streptokinase)4 | Myocardial infarction | US$32678 | GUSTO + projection |
Implantable defibrillator6 | High risk of sudden death | US$37000–infinite | Model |
IHD, ischaemic heart disease; QALY, quality adjusted life-years.